Activation of immune responses to brain antigens after stroke

Journal of Neurochemistry

Volumn 123, Issue SUPPL. 2, 2012, Pages 148-155

  Becker, Kyra J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

autoimmune; infection; MBP; stroke; TH1; TREG

Indexed keywords

ANTIGEN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BYSTANDER EFFECT; CELLULAR IMMUNITY; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; DISEASE ASSOCIATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFECTION RISK; LYMPHOCYTOPENIA; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; URINARY TRACT INFECTION;

ANIMALS; ANTIGENS; AUTOIMMUNITY; BRAIN; HUMANS; INFECTION; MODELS, BIOLOGICAL; MONOCYTES; STROKE;

EID: 84867569785     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07953.x     Document Type: Conference Paper

References (82)

1. Ali C., Docagne F., Nicole O., et al,. (2001) Increased expression of transforming growth factor-beta after cerebral ischemia in the baboon: an endogenous marker of neuronal stress? J. Cereb. Blood Flow Metab. 21, 820-827.
2. Aslanyan S., Weir C. J., Diener H. C., Kaste M., and, Lees K. R., (2004) Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur. J. Neurol. 11, 49-53.
3. Bailey S. L., Carpentier P. A., McMahon E. J., Begolka W. S., and, Miller S. D., (2006) Innate and adaptive immune responses of the central nervous system. Crit. Rev. Immunol. 26, 149-188.
4. Bauer S., Muller T., and, Hamm S., (2009) Pattern recognition by Toll-like receptors. Adv. Exp. Med. Biol. 653, 15-34.
5. Becker K., Kindrick D., Relton J., Harlan J., and, Winn R., (2001) Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke 32, 206-211.
6. Becker K. J., Kindrick D. L., Lester M. P., Shea C., and, Ye Z. C., (2005) Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J. Cereb. Blood Flow Metab. 25, 1634-1644.
7. Becker K. J., Kalil A. J., Tanzi P., et al,. (2011) Autoimmune Responses to the Brain After Stroke Are Associated With Worse Outcome. Stroke 42, 2763-2769.
8. Bornstein N. M., Aronovich B., Korczyn A. D., Shavit S., Michaelson D. M., and, Chapman J., (2001) Antibodies to brain antigens following stroke. Neurology 56, 529-530.
9. Brea D., Blanco M., Ramos-Cabrer P., Moldes O., Arias S., Perez-Mato M., Leira R., Sobrino T., and, Castillo J., (2011) Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values. J. Cereb. Blood Flow Metab. 31, 1424-1431.
10. Chamorro A., Amaro S., Vargas M., Obach V., Cervera A., Torres F., and, Planas A. M., (2006) Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 77, 1279-1281.
11. Chamorro A., Amaro S., Vargas M., Obach V., Cervera A., Gomez-Choco M., Torres F., and, Planas A. M., (2007) Catecholamines, infection, and death in acute ischemic stroke. J. Neurol. Sci. 252, 29-35.
12. Chen B., Friedman B., Cheng Q., Tsai P., Schim E., Kleinfeld D., and, Lyden P. D., (2009) Severe blood-brain barrier disruption and surrounding tissue injury. Stroke 40, e666-674.
13. Czech B., Pfeilschifter W., Mazaheri-Omrani N., Strobel M. A., Kahles T., Neumann-Haefelin T., Rami A., Huwiler A., and, Pfeilschifter J., (2009) The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochem. Biophys. Res. Commun. 389, 251-256.
14. Czlonkowska A., Cyrta B., and, Korlak J., (1979) Immunological observations on patients with acute cerebral vascular disease. J. Neurol. Sci. 43, 455-464.
15. Dambinova S. A., Khounteev G. A., Izykenova G. A., Zavolokov I. G., Ilyukhina A. Y., and, Skoromets A. A., (2003) Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem. 49, 1752-1762.
16. Dangond F., Windhagen A., Groves C. J., and, Hafler D. A., (1997) Constitutive expression of costimulatory molecules by human microglia and its relevance to CNS autoimmunity. J. Neuroimmunol. 76, 132-138.
17. Denes A., Humphreys N., Lane T. E., Grencis R., and, Rothwell N., (2010) Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J. Neurosci. 30, 10086-10095.
18. Felger J. C., Abe T., Kaunzner U. W., Gottfried-Blackmore A., Gal-Toth J., McEwen B. S., Iadecola C., and, Bulloch K., (2010) Brain dendritic cells in ischemic stroke: time course, activation state, and origin. Brain Behav. Immun. 24, 724-737.
19. Ferrarese C., Mascarucci P., Zoia C., Cavarretta R., Frigo M., Begni B., Sarinella F., Frattola L., and, De Simoni M. G., (1999) Increased cytokine release from peripheral blood cells after acute stroke. J. Cereb. Blood Flow Metab. 19, 1004-1009.
20. Gee J. M., Kalil A., Thullbery M., and, Becker K. J., (2008) Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke. Stroke 39, 1575-1582.
21. Gee J. M., Zierath D., Hadwin J., Savos A., Kalil A., Thullbery M., and, Becker K. J., (2009) Long term immunologic consequences of experimental stroke and mucosal tolerance. Exp. Transl. Stroke Med. 1, 3.
22. Gottfried-Blackmore A., Kaunzner U. W., Idoyaga J., Felger J. C., McEwen B. S., and, Bulloch K., (2009) Acute in vivo exposure to interferon-gamma enables resident brain dendritic cells to become effective antigen presenting cells. Proc. Natl Acad. Sci. USA 106, 20918-20923.
23. Grabska K., Gromadzka G., and, Czlonkowska A., (2011) Infections and ischemic stroke outcome. Neurol. Res. Int. 2011, 691348.
24. Grau A. J., Urbanek C., and, Palm F., (2010) Common infections and the risk of stroke. Nat. Rev. Neurol. 6, 681-694.
25. Haeusler K. G., Schmidt W. U., Fohring F., et al,. (2008) Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc. Dis. 25, 50-58.
26. Haeusler K. G., Schmidt W. U., Foehring F., et al,. (2012) Immune responses after acute ischemic stroke or myocardial infarction. Int. J. Cardiol. 155, 372-377.
27. Harms H., Reimnitz P., Bohner G., Werich T., Klingebiel R., Meisel C., and, Meisel A., (2011) Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc. Dis. 32, 552-560.
28. Hasegawa Y., Suzuki H., Sozen T., Rolland W., and, Zhang J. H., (2010) Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41, 368-374.
29. Herrmann M., Vos P., Wunderlich M. T., de Bruijn C. H., and, Lamers K. J., (2000) Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 31, 2670-2677.
30. Hong K. S., Kang D. W., Koo J. S., Yu K. H., Han M. K., Cho Y. J., Park J. M., Bae H. J., and, Lee B. C., (2008) Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur. J. Neurol. 15, 1324-1331.
31. Hug A., Dalpke A., Wieczorek N., Giese T., Lorenz A., Auffarth G., Liesz A., and, Veltkamp R., (2009) Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke 40, 3226-3232.
32. Hug A., Liesz A., Muerle B., Zhou W., Ehrenheim J., Lorenz A., Dalpke A., and, Veltkamp R., (2011) Reduced efficacy of circulating costimulatory cells after focal cerebral ischemia. Stroke 42, 3580-3586.
33. Intiso D., Zarrelli M. M., Lagioia G., Di Rienzo F., Checchia De Ambrosio C., Simone P., Tonali P., and, Cioffi Dagger R. P., (2004) Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol. Sci. 24, 390-396.
34. Jander S., Kraemer M., Schroeter M., Witte O. W., and, Stoll G., (1995) Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J. Cereb. Blood Flow Metab. 15, 42-51.
35. Jauch E. C., Lindsell C., Broderick J., Fagan S. C., Tilley B. C., and, Levine S. R., (2006) Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 37, 2508-2513.
36. Kallen B., Nilsson O., and, Thelin C., (1977) Effect of encephalitogenic protein on migration in agarose of leukoytes from patients with multiple sclerosis. A longitudinal study of patients with relapsing multiple sclerosis or with cerebral infarction. Acta Neurol. Scand. 55, 47-56.
37. Klehmet J., Harms H., Richter M., Prass K., Volk H. D., Dirnagl U., Meisel A., and, Meisel C., (2009) Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 158, 1184-1193.
38. Krupinski J., Kumar P., Kumar S., and, Kaluza J., (1996) Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke 27, 852-857.
39. Liesz A., Hagmann S., Zschoche C., et al,. (2009a) The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 40, 2849-2858.
40. Liesz A., Suri-Payer E., Veltkamp C., Doerr H., Sommer C., Rivest S., Giese T., and, Veltkamp R., (2009b) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15, 192-199.
41. Liesz A., Sun L., Zhou W., Schwarting S., Mracsko E., Zorn M., Bauer H., Sommer C., and, Veltkamp R., (2011a) FTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemia. PLoS ONE 6, e21312.
42. Liesz A., Zhou W., Mracsko E., et al,. (2011b) Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134, 704-720.
43. Mannie M., Swanborg R. H., and, Stepaniak J. A., (2009) Experimental autoimmune encephalomyelitis in the rat. Curr. Protoc. Immunol. (Suppl. 85), 15.2.1-15.2.15 Chapter 15, Unit 15.2.
44. Mazzotta G., Sarchielli P., Caso V., Paciaroni M., Floridi A., Floridi A., and, Gallai V., (2004) Different cytokine levels in thrombolysis patients as predictors for clinical outcome. Eur. J. Neurol. 11, 377-381.
45. Meisel C., Prass K., Braun J., et al,. (2004) Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 35, 2-6.
46. Montaner J., Rovira A., Molina C. A., Arenillas J. F., Ribo M., Chacon P., Monasterio J., and, Alvarez-Sabin J., (2003) Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J. Cereb. Blood Flow Metab. 23, 1403-1407.
47. Offner H., Subramanian S., Parker S. M., Afentoulis M. E., Vandenbark A. A., and, Hurn P. D., (2006) Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 26, 654-665.
48. Olson J. K., and, Miller S. D., (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173, 3916-3924.
49. Planas A. M., Gomez-Choco M., Urra X., Gorina R., Caballero M., and, Chamorro A., (2012) Brain-derived antigens in lymphoid tissue of patients with acute stroke. J. Immunol. 188, 2156-2163.
50. Prass K., Meisel C., Hoflich C., et al,. (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 198, 725-736.
51. Raymond C. R., and, Wilkie B. N., (2005) Toll-like receptor, MHC II, B7 and cytokine expression by porcine monocytes and monocyte-derived dendritic cells in response to microbial pathogen-associated molecular patterns. Vet. Immunol. Immunopathol. 107, 235-247.
52. Relton J. K., Sloan K. E., Frew E. M., Whalley E. T., Adams S. P., and, Lobb R. R., (2001) Inhibition of alpha4 integrin protects against transient focal cerebral ischemia in normotensive and hypertensive rats. Stroke 32, 199-205.
53. Ren X., Akiyoshi K., Vandenbark A. A., Hurn P. D., and, Offner H., (2011) CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab. Brain Dis. 26, 87-90.
54. Rogers S. L., Coe C. L., and, Karaszewski J. W., (1998) Immune consequences of stroke and cerebral palsy in adults. J. Neuroimmunol. 91, 113-120.
55. Romo-Gonzalez T., Chavarria A., and, Perez H. J., (2012) Central nervous system: a modified immune surveillance circuit?. Brain Behav. Immun. 26, 823-829.
56. Schroeter M., Jander S., Witte O. W., and, Stoll G., (1994) Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J. Neuroimmunol. 55, 195-203.
57. Schulte-Herbruggen O., Klehmet J., Quarcoo D., Meisel C., and, Meisel A., (2006) Mouse strains differ in their susceptibility to poststroke infections. NeuroImmunoModulation 13, 13-18.
58. Sfriso P., Ghirardello A., Botsios C., Tonon M., Zen M., Bassi N., Bassetto F., and, Doria A., (2010) Infections and autoimmunity: the multifaceted relationship. J. Leukoc. Biol. 87, 385-395.
59. Sotgiu S., Zanda B., Marchetti B., et al,. (2006) Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur. J. Neurol. 13, 505-513.
60. Suter T., Biollaz G., Gatto D., Bernasconi L., Herren T., Reith W., and, Fontana A., (2003) The brain as an immune privileged site: dendritic cells of the central nervous system inhibit T cell activation. Eur. J. Immunol. 33, 2998-3006.
61. Tamayo E., Fernandez A., Almansa R., et al,. (2011) Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur. Cytokine Netw. 22, 82-87.
62. Tanzi P., Cain K., Kalil A., et al,. (2011) Post-stroke infection: a role for IL-1ra? Neurocrit. Care 14, 244-252.
63. Tuttolomondo A., Di Sciacca R., Di Raimondo D., et al,. (2009) Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J. Neuroimmunol. 215, 84-89.
64. Urra X., Cervera A., Obach V., Climent N., Planas A. M., and, Chamorro A., (2009a) Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke 40, 1262-1268.
65. Urra X., Cervera A., Villamor N., Planas A. M., and, Chamorro A., (2009b) Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 158, 1174-1183.
66. Urra X., Villamor N., Amaro S., Gomez-Choco M., Obach V., Oleaga L., Planas A. M., and, Chamorro A., (2009c) Monocyte subtypes predict clinical course and prognosis in human stroke. J. Cereb Blood Flow Metab 29, 994-1002.
67. Vermeij F. H., Scholte op Reimer W. J., de Man P., van Oostenbrugge R. J., Franke C. L., de Jong G., de Kort P. L., and, Dippel D. W., (2009) Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc. Dis. 27, 465-471.
68. Vogelgesang A., Grunwald U., Langner S., Jack R., Broker B. M., Kessler C., and, Dressel A., (2008) Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 39, 237-241.
69. Vogelgesang A., May V. E., Grunwald U., Bakkeboe M., Langner S., Wallaschofski H., Kessler C., Broker B. M., and, Dressel A., (2010) Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS ONE 5, e8718.
70. Wang W. Z., Olsson T., Kostulas V., Hojeberg B., Ekre H. P., and, Link H., (1992) Myelin antigen reactive T cells in cerebrovascular diseases. Clin. Exp. Immunol. 88, 157-162.
71. Wei Y., Yemisci M., Kim H. H., et al,. (2011) Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann. Neurol. 69, 119-129.
72. de Werra I., Jaccard C., Corradin S. B., et al,. (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit. Care Med. 25, 607-613.
73. Westendorp W. F., Nederkoorn P. J., Vermeij J. D., Dijkgraaf M. G., and, van de Beek D., (2011) Post-stroke infection: a systematic review and meta-analysis. BMC Neurol. 11, 110.
74. Wong C. H., Jenne C. N., Lee W. Y., Leger C., and, Kubes P., (2011) Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 334, 101-105.
75. Yan J., Read S. J., Henderson R. D., Hull R., O'Sullivan J. D., McCombe P. A., and, Greer J. M., (2012) Frequency and function of regulatory T cells after ischaemic stroke in humans. J. Neuroimmunol. 243, 89-94.
76. Yang Q. W., Li J. C., Lu F. L., Wen A. Q., Xiang J., Zhang L. L., Huang Z. Y., and, Wang J. Z., (2008) Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction. J. Cereb. Blood Flow Metab. 28, 1588-1596.
77. Youngchaiyud U., Coates A. S., Whittingham S., and, Mackay I. R., (1974) Cellular-immune response to myelin protein: absence in multiple sclerosis and presence in cerebrovascular accidents. Aust. N. Z. J. Med. 4, 535-538.
78. Zaremba J., and, Losy J., (2001) Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol. Scand. 104, 288-295.
79. Zhang D. P., Yan F. L., Xu H. Q., Zhu Y. X., Yin Y., and, Lu H. Q., (2009) A decrease of human leucocyte antigen-DR expression on monocytes in peripheral blood predicts stroke-associated infection in critically-ill patients with acute stroke. Eur. J. Neurol. 16, 498-505.
80. Zierath D., Thullbery M., Hadwin J., Gee J. M., Savos A., Kalil A., and, Becker K. J., (2010) CNS immune responses following experimental stroke. Neurocrit Care 12, 274-284.
81. van Zwam M., Huizinga R., Melief M. J., et al,. (2009) Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. J. Mol. Med. 87, 273-286.
82. Zygmunt B., and, Veldhoen M., (2011) T helper cell differentiation more than just cytokines. Adv. Immunol. 109, 159-196.